Michael A Zeligs

This inventor holds 23 USPTO granted patents and 3 published patent applications, plus 5 CIPO patents and 3 EPO patents, primarily in Phytochemical Therapeutics. Top assignees: Bioresponse, LLC, Boulder Bioscience LLC, Other. Active years: 2000-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael A Zeligs. Retrieved from https://idiyas.com/inventor/michael-a-zeligs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 3)

% Patents Active = 60.9

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 1.3

ph-index = 10

Forward Citations = 313(Granted Patents)

Location History:

Long Beach, CA (US) (2000)
Boulder, CO (US) (2000 - 2024)

Company Filing History:

Boulder Bioscience LLC

patents

1 out of 834,513

Other

patents

Years Active: 2000-2026

Loading Chart...

Areas of Expertise:

Diindolylmethane

Phytochemicals

Endovascular Thrombectomy

Acute Coronary Syndrome

Respiratory Syncytial Virus

HPV Infection

Weight Loss

Leiomyomas

Cervical Dysplasia

Mastalgia

Steroid Hormone Metabolism

Controlled-Release Alkaloids

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12527766 - Methods of treating acute coronary syndrome using 3,3'-diindolylmethane (2026-01-20),

2. 12171745 - Compositions and methods for treating non-hemorrhagic closed head injury (2024-12-24),

3. 11980604 - Methods for improved endovascular thrombectomy using 3,3′-diindolylmethane (2024-05-14),

4. 11529331 - Methods for improved endovascular thrombectomy using 3,3'-diindolylmethane (2022-12-20),

5. 11337961 - Self-emulsifying formulations of DIM-related indoles (2022-05-24),

6. 10799479 - Self-emulsifying formulations of DIM-related indoles (2020-10-13),

7. 10441569 - Self-emulsifying formulations of DIM-related indoles (2019-10-15),

8. 9918965 - Self-emulsifying formulations of DIM-related indoles (2018-03-20),

9. 9663462 - Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles (2017-05-30),

10. 9353058 - Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles (2016-05-31),

11. 8586621 - Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles (2013-11-19),

12. 8552052 - Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions (2013-10-08),

13. 8236848 - Diindolylmethane for the treatment of HPV infection (2012-08-07),

14. 8080577 - Diindolylmethane formulations for the treatment of leiomyomas (2011-12-20),

15. 7989486 - Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions (2011-08-02),

Title: Innovations and Contributions of Michael A Zeligs

Introduction

Michael A Zeligs is a prominent inventor based in Boulder, Colorado, known for his significant contributions to the field of medical treatments and devices. With a remarkable portfolio of 22 patents, Zeligs has focused on advancing methodologies and compositions essential in addressing critical health issues, particularly in the realm of brain injuries.

Latest Patents

Among his latest innovations, Zeligs has developed groundbreaking patents aimed at treating non-hemorrhagic closed head injuries (NHCHI). His work includes methods utilizing 3,3'-diindolylmethane or its analogs, specifically designed to address various forms of Traumatic Brain Injuries (TBIs). These encompass a range of conditions, from mild concussions to severe injuries associated with blasts or deceleration events. Additionally, Zeligs has contributed methods for improving endovascular thrombectomy procedures during acute thrombosis, leveraging 3,3′-diindolylmethane to enhance mechanical thrombectomy efficiency.

Career Highlights

Zeligs has had a fruitful career, marked by his affiliation with companies dedicated to medical advancements. He has collaborated with Bioresponse LLC and Boulder Bioscience LLC, both of which have played pivotal roles in bringing innovative medical solutions to the forefront. His inventions not only exemplify his expertise but also reflect a commitment to improving patient outcomes through scientific research and application.

Collaborations

In addition to his own inventions, Michael A Zeligs has worked alongside esteemed colleagues, including Irwin C Jacobs. These collaborations have further enriched the environment of innovation and have fostered the development of valuable patents that address significant health challenges.

Conclusion

In conclusion, Michael A Zeligs stands out as a key innovator in the medical field, with substantial contributions reflected in his numerous patents. His work in treating brain injuries and enhancing medical procedures demonstrates a profound understanding of complex health issues. As he continues to push the boundaries of innovation, Zeligs exemplifies the vital role inventors play in shaping the future of medical science and technology.

Profile summary based on public USPTO records.